1-methyl-3-isobutylxanthine and eg 626

1-methyl-3-isobutylxanthine has been researched along with eg 626 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bristol, JA; Cain, MH; Weishaar, RE1
Azuma, H; Ishikawa, M; Takashima, Y; Yamakado, T1

Reviews

1 review(s) available for 1-methyl-3-isobutylxanthine and eg 626

ArticleYear
A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; Calmodulin; Cardiotonic Agents; Guinea Pigs; Humans; Hypersensitivity; In Vitro Techniques; Lung Diseases; Myocardium; Platelet Aggregation; Substrate Specificity

1985

Other Studies

1 other study(ies) available for 1-methyl-3-isobutylxanthine and eg 626

ArticleYear
Potentiation of antiaggregating activity of adenosine by a phosphodiesterase inhibitor, EG626 (oxagrelate), in human platelets in vitro.
    Japanese journal of pharmacology, 1984, Volume: 34, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenosine Deaminase Inhibitors; Adenylyl Cyclases; Coformycin; Collagen; Cyclic AMP; Drug Synergism; Humans; In Vitro Techniques; Male; Pentostatin; Phosphodiesterase Inhibitors; Phthalazines; Platelet Aggregation; Pyridazines

1984